TFS Capital’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

TFS Capital’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-75,501	Closed	-$119K	–	413
2017 Q2	$119K	Buy	+75,501	New	+$146K	0.05%	529
2016 Q2	–	Sell	-399,320	Closed	-$2.1M	–	1227
2016 Q1	$2.1M	Buy	399,320 +385,957	+2,888%	+$2.36M	0.3%	52
2015 Q4	$105K	Buy	+13,363	New	+$115K	0.01%	654
2015 Q1	–	Sell	-347,088	Closed	-$5.86M	–	1168
2014 Q4	$5.86M	Buy	+347,088	New	+$5.05M	0.56%	5

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TFS Capital's INFI Position: Q3 2017 in Review

TFS Capital sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2017, closing a stake of 75,501 shares — an estimated $119K sold.

TFS Capital first reported a position in INFI in Q4 2014 and held it in 4 quarters. The position peaked at $5.86M in Q4 2014. 63 funds tracked by Wall St. Rank hold INFI as of Q3 2017.

TFS Capital reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
TFS Capital sold 75,501 Infinity Pharmaceuticals, Inc. shares in Q3 2017, an estimated $119K.
TFS Capital first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 4 quarters.
TFS Capital's Infinity Pharmaceuticals, Inc. position peaked at $5.86M in Q4 2014.
63 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.